Physician Assistant in Rockport, TX Accepting Medicare

3 Physician Assistant nurses found. Showing 1 - 3

Mr. Randy Dwayne Bingham, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1704 Jenkins St, Rockport, TX 78382 Phone: 361-790-9047    Fax: 361-790-9615

Raffaele D Giovannone, P.A. - C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1209 Highway 35 N, Suite A, Rockport, TX 78382 Phone: 361-729-9811    Fax: 361-729-9819

Mr. William Lewis Marr Iv, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1209 Highway 35 N, Rockport, TX 78382 Phone: 361-729-9811    Fax: 361-729-9819

News Archive

Uniting announces recipient of 'Caine Halter Hope Now Award for Lung Cancer Research'

Uniting Against Lung Cancer (Uniting) announces the "Caine Halter Hope Now Award for Lung Cancer Research."

Cequent Pharmaceuticals commences toxicology study of CEQ508 tkRNAi-based therapeutic candidate

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has initiated a long-term (26-week) toxicology study of CEQ508 – the company's lead drug candidate based on its proprietary tkRNAi technology. This study is designed to enable a Phase II clinical trial slated for 2011. CEQ508 targets beta-catenin, a key oncogene implicated in the formation of colonic polyps and in the progression of polyps to colorectal cancer.

First Edition: June 16, 2011

In today's headlines, reports about the prospect for Medicaid cutbacks in an emerging bipartisan budget deal, as well as how a report from a Medicare advisory panel may bolster Medicare options currently on the table.

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

Centric Health second-quarter net income increases 154% to $1.3 million

Centric Health Corporation, a diversified healthcare company with a vision to become Canada's premier healthcare company providing innovative solutions centered around patients and healthcare professionals, today announced strong financial results for the second quarter ended June 30, 2010.

Read more Medical News

› Verified 6 days ago